Matei Vaduva is a Research Analyst at Cornucopian Capital, conducting scientific diligence and technical validation. He previously worked in a biomedical engineering lab at Brown University and interned with GSK's virology vaccine division.
At firms with a similar stage, sector and check size.





One email when Matei's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMatei Vaduva is a Research Analyst at Cornucopian Capital, conducting scientific diligence and technical validation. He previously worked in a biomedical engineering lab at Brown University and interned with GSK's virology vaccine division.
Matei Vaduva invests through Cornucopian Capital, which writes checks of $250K to $10M at pre-seed, seed, series a, series b.
A warm intro from a founder Cornucopian Capital backed works best.
biomedical engineering lab researcher at Brown University; rotation with asset management team at FM; venture investing at Lever VC.
Last updated 2026-10-15. Is this you? Ask for a correction.